(Q44254755)

1 December 2017

title

Interferon-alpha therapy in HCV hepatitis: HLA phenotype and cirrhosis are independent predictors of clinical outcome (English)

1 reference

1 December 2017

0 references

Almarri A

1

1 reference

1 December 2017

El Dwick N

2

1 reference

1 December 2017

Al Kabi S

3

1 reference

1 December 2017

Sleem K

4

1 reference

1 December 2017

Rashed A

5

1 reference

1 December 2017

Ritter MA

6

1 reference

1 December 2017

Batchelor JR

7

1 reference

1 December 2017

publication date

1 April 1998

1 reference

1 December 2017

1 reference

1 December 2017

volume

59

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

239-242

1 reference

Hepatitis C virus six years on.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Interferon for non-A, non-B chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Antiviral therapy of hepatitis C--present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Management of Chronic Viral Hepatitis in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

HCV genotypes in chronic hepatitis C and response to interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Factors useful in predicting the response to interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Clinical backgrounds of the patients having different types of hepatitis C virus genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Hepatitis C serotype and response to interferon therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Quantitative analysis of hepatitis C virus RNA: relationship between the replicative level and the various stages of the carrier states or the response to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

HLA and hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Prediction of response to interferon treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Repeated course of interferon treatment in chronic hepatitis B in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2898%2900010-X

7 January 2021

10.1016/S0198-8859(98)00010-X

Identifiers

DOI

1 reference

1 December 2017

1 reference